The novel ETA receptor antagonist HJP-272 prevents cerebral microvascular hemorrhage in cerebral malaria and synergistically improves survival in combination with an artemisinin derivative

Autor: Dai, Minxian, Freeman, Brandi, Bruno, Fernando P., Shikani, Henry J., Tanowitz, Herbert B., Weiss, Louis M., Reznik, Sandra E., Stephani, Ralph A., Desruisseaux, Mahalia S.
Zdroj: In Life Sciences 15 October 2012 91(13-14):687-692
Databáze: ScienceDirect
Externí odkaz: